The present study suggested that ALA alleviated hepatic IR and liver‐free fatty acid contents by inhibiting the secondary activation signal of the NLRP3 inflammasome and reducing cytokine production in the livers of T2DM model rats. This evidence concerns the gene NLRP3 and type 2 diabetes mellitus.